skip to main content
Idioma:
Primo Advanced Search
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search prefilters
Busca Simples
Refinado por: Nome da Publicação: Cancer remover
Result Number Material Type Add to My Shelf Action Record Details and Options
11
Cytogenetic risk determines outcomes after allogeneic transplantation in older patients with acute myeloid leukemia in their second complete remission: A Center for International Blood and Marrow Transplant Research cohort analysis
Cytogenetic risk determines outcomes after allogeneic transplantation in older patients with acute myeloid leukemia in their second complete remission: A Center for International Blood and Marrow Transplant Research cohort analysis
Material Type:
Artigo 		Adicionar ao Meu Espaço

Cytogenetic risk determines outcomes after allogeneic transplantation in older patients with acute myeloid leukemia in their second complete remission: A Center for International Blood and Marrow Transplant Research cohort analysis

Michelis, Fotios V. ; Gupta, Vikas ; Zhang, Mei‐Jie ; Wang, Hai‐Lin ; Aljurf, Mahmoud ; Bacher, Ulrike ; Beitinjaneh, Amer ; Chen, Yi‐Bin ; DeFilipp, Zachariah ; Gale, Robert Peter ; Kebriaei, Partow ; Kharfan‐Dabaja, Mohamed ; Lazarus, Hillard M. ; Nishihori, Taiga ; Olsson, Richard F. ; Oran, Betul ; Rashidi, Armin ; Rizzieri, David A. ; Tallman, Martin S. ; de Lima, Marcos ; Khoury, H. Jean ; Sandmaier, Brenda M. ; Weisdorf, Daniel ; Saber, Wael

Cancer, 2017-06, Vol.123 (11), p.2035-2042 [Periódico revisado por pares]

United States: Wiley Subscription Services, Inc

Texto completo disponível

Citações Citado por
12
Dose‐intensive chemotherapy including rituximab in Burkitt's leukemia or lymphoma regardless of human immunodeficiency virus infection status
Dose‐intensive chemotherapy including rituximab in Burkitt's leukemia or lymphoma regardless of human immunodeficiency virus infection status
Material Type:
Artigo 		Adicionar ao Meu Espaço

Dose‐intensive chemotherapy including rituximab in Burkitt's leukemia or lymphoma regardless of human immunodeficiency virus infection status

Ribera, Josep‐Maria ; García, Olga ; Grande, Carlos ; Esteve, Jordi ; Oriol, Albert ; Bergua, Juan ; González‐Campos, José ; Vall‐llovera, Ferran ; Tormo, Mar ; Hernández‐Rivas, Jesús‐Maria ; García, Daniel ; Brunet, Salut ; Alonso, Natalia ; Barba, Pere ; Miralles, Pilar ; Llorente, Andreu ; Montesinos, Pau ; Moreno, Maria‐José ; Hernández‐Rivas, Jose‐Ángel ; Bernal, Teresa

Cancer, 2013-05, Vol.119 (9), p.1660-1668 [Periódico revisado por pares]

Hoboken: Wiley Subscription Services, Inc., A Wiley Company

Texto completo disponível

Citações Citado por
13
Dose-Intensive Chemotherapy Including Rituximab in Burkitt's Leukemia or Lymphoma Regardless of Human Immunodeficiency Virus Infection Status: Final Results of a Phase 2 Study (Burkimab)
Dose-Intensive Chemotherapy Including Rituximab in Burkitt's Leukemia or Lymphoma Regardless of Human Immunodeficiency Virus Infection Status: Final Results of a Phase 2 Study (Burkimab)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Dose-Intensive Chemotherapy Including Rituximab in Burkitt's Leukemia or Lymphoma Regardless of Human Immunodeficiency Virus Infection Status: Final Results of a Phase 2 Study (Burkimab)

RIBERA, Josep-Maria ; GARCIA, Olga ; GARCIA, Daniel ; BRUNET, Salut ; ALONSO, Natalia ; BARBA, Pere ; MIRALLES, Pilar ; LLORENTE, Andreu ; MONTESINOS, Pau ; MORENO, Maria-José ; HERNANDEZ-RIVAS, Jose-Angel ; BERNAL, Teresa ; GRANDE, Carlos ; ESTEVE, Jordi ; ORIOL, Albert ; BERGUA, Juan ; GONZALEZ-CAMPOS, Jose ; VALL-ILOVERA, Ferran ; TORMO, Mar ; HERNANDEZ-RIVAS, Jesus-Maria

Cancer, 2013-05, Vol.119 (9), p.1660-1668 [Periódico revisado por pares]

Hoboken, NJ: Wiley-Blackwell

Texto completo disponível

Citações Citado por
14
Dose, schedule, safety, and efficacy of guadecitabine in relapsed or refractory acute myeloid leukemia
Dose, schedule, safety, and efficacy of guadecitabine in relapsed or refractory acute myeloid leukemia
Material Type:
Artigo 		Adicionar ao Meu Espaço

Dose, schedule, safety, and efficacy of guadecitabine in relapsed or refractory acute myeloid leukemia

Roboz, Gail J. ; Kantarjian, Hagop M. ; Yee, Karen W. L. ; Kropf, Patricia L. ; O'Connell, Casey L. ; Griffiths, Elizabeth A. ; Stock, Wendy ; Daver, Naval G. ; Jabbour, Elias ; Ritchie, Ellen K. ; Walsh, Katherine J. ; Rizzieri, David ; Lunin, Scott D. ; Curio, Tania ; Chung, Woonbok ; Hao, Yong ; Lowder, James N. ; Azab, Mohammad ; Issa, Jean‐Pierre J.

Cancer, 2018-01, Vol.124 (2), p.325-334 [Periódico revisado por pares]

United States: Wiley Subscription Services, Inc

Texto completo disponível

Citações Citado por
15
Final results of a phase 2 trial of clofarabine and low‐dose cytarabine alternating with decitabine in older patients with newly diagnosed acute myeloid leukemia
Final results of a phase 2 trial of clofarabine and low‐dose cytarabine alternating with decitabine in older patients with newly diagnosed acute myeloid leukemia
Material Type:
Artigo 		Adicionar ao Meu Espaço

Final results of a phase 2 trial of clofarabine and low‐dose cytarabine alternating with decitabine in older patients with newly diagnosed acute myeloid leukemia

Kadia, Tapan M. ; Faderl, Stefan ; Ravandi, Farhad ; Jabbour, Elias ; Garcia‐Manero, Guillermo ; Borthakur, Gautam ; Ferrajoli, Alessandra ; Konopleva, Marina ; Burger, Jan ; Huang, Xuelin ; Wang, Xuemei ; Pierce, Sherry ; Brandt, Mark ; Feliu, Jennie ; Cortes, Jorge ; Kantarjian, Hagop

Cancer, 2015-07, Vol.121 (14), p.2375-2382 [Periódico revisado por pares]

United States: Wiley Subscription Services, Inc

Texto completo disponível

Citações Citado por
16
Hematopoietic cell transplantation‐comorbidity index and Karnofsky performance status are independent predictors of morbidity and mortality after allogeneic nonmyeloablative hematopoietic cell transplantation
Hematopoietic cell transplantation‐comorbidity index and Karnofsky performance status are independent predictors of morbidity and mortality after allogeneic nonmyeloablative hematopoietic cell transplantation
Material Type:
Artigo 		Adicionar ao Meu Espaço

Hematopoietic cell transplantation‐comorbidity index and Karnofsky performance status are independent predictors of morbidity and mortality after allogeneic nonmyeloablative hematopoietic cell transplantation

Sorror, Mohamed ; Storer, Barry ; Sandmaier, Brenda M. ; Maloney, David G. ; Chauncey, Thomas R. ; Langston, Amelia ; Maziarz, Richard T. ; Pulsipher, Michael ; McSweeney, Peter A. ; Storb, Rainer

Cancer, 2008-05, Vol.112 (9), p.1992-2001 [Periódico revisado por pares]

Hoboken: Wiley Subscription Services, Inc., A Wiley Company

Texto completo disponível

Citações Citado por
17
High‐dose cytarabine induction is well tolerated and active in patients with de novo acute myeloid leukemia older than 60 years
High‐dose cytarabine induction is well tolerated and active in patients with de novo acute myeloid leukemia older than 60 years
Material Type:
Artigo 		Adicionar ao Meu Espaço

High‐dose cytarabine induction is well tolerated and active in patients with de novo acute myeloid leukemia older than 60 years

Arellano, Martha ; Winton, Elliott ; Pan, Lin ; Lima, Lisa ; Tighiouart, Mourad ; Bhalla, Kapil ; Heffner, Leonard T. ; Neely, Jessica ; Hutcherson, Donald ; McLemore, Morgan ; Langston, Amelia ; Khoury, H. Jean

Cancer, 2012-01, Vol.118 (2), p.428-433 [Periódico revisado por pares]

Hoboken: Wiley Subscription Services, Inc., A Wiley Company

Texto completo disponível

Citações Citado por
18
Hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone and highly active antiretroviral therapy for patients with acquired immunodeficiency syndrome‐related burkitt lymphoma/leukemia
Hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone and highly active antiretroviral therapy for patients with acquired immunodeficiency syndrome‐related burkitt lymphoma/leukemia
Material Type:
Artigo 		Adicionar ao Meu Espaço

Hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone and highly active antiretroviral therapy for patients with acquired immunodeficiency syndrome‐related burkitt lymphoma/leukemia

Cortes, Jorge ; Thomas, Deborah ; Rios, Adan ; Koller, Charles ; O'Brien, Susan ; Jeha, Sima ; Faderl, Stefan ; Kantarjian, Hagop

Cancer, 2002-03, Vol.94 (5), p.1492-1499 [Periódico revisado por pares]

New York: John Wiley & Sons, Inc

Texto completo disponível

Citações Citado por
19
Impact of conditioning intensity on outcomes of haploidentical stem cell transplantation for patients with acute myeloid leukemia 45 years of age and over
Impact of conditioning intensity on outcomes of haploidentical stem cell transplantation for patients with acute myeloid leukemia 45 years of age and over
Material Type:
Artigo 		Adicionar ao Meu Espaço

Impact of conditioning intensity on outcomes of haploidentical stem cell transplantation for patients with acute myeloid leukemia 45 years of age and over

Santoro, Nicole ; Labopin, Myriam ; Ciceri, Fabio ; Van Lint, Maria Teresa ; Nasso, Daniela ; Blaise, Didier ; Arcese, William ; Tischer, Johanna ; Bruno, Benedetto ; Ehninger, Gerhard ; Koc, Yener ; Santarone, Stella ; Huang, Xiao‐Jun ; Savani, Bipin N. ; Mohty, Mohamad ; Ruggeri, Annalisa ; Nagler, Arnon

Cancer, 2019-05, Vol.125 (9), p.1499-1506 [Periódico revisado por pares]

United States: Wiley Subscription Services, Inc

Texto completo disponível

Citações Citado por
20
Impact of pre‐transplant depression on outcomes of allogeneic and autologous hematopoietic stem cell transplantation
Impact of pre‐transplant depression on outcomes of allogeneic and autologous hematopoietic stem cell transplantation
Material Type:
Artigo 		Adicionar ao Meu Espaço

Impact of pre‐transplant depression on outcomes of allogeneic and autologous hematopoietic stem cell transplantation

El‐Jawahri, Areej ; Chen, Yi‐Bin ; Brazauskas, Ruta ; He, Naya ; Lee, Stephanie J. ; Knight, Jennifer M. ; Majhail, Navneet ; Buchbinder, David ; Schears, Raquel M. ; Wirk, Baldeep M. ; Wood, William A. ; Ahmed, Ibrahim ; Aljurf, Mahmoud ; Szer, Jeff ; Beattie, Sara M. ; Battiwalla, Minoo ; Dandoy, Christopher ; Diaz, Miguel‐Angel ; D'Souza, Anita ; Freytes, Cesar O. ; Gajewski, James ; Gergis, Usama ; Hashmi, Shahrukh K. ; Jakubowski, Ann ; Kamble, Rammurti T. ; Kindwall‐Keller, Tamila ; Lazarus, Hilard M. ; Malone, Adriana K. ; Marks, David I. ; Meehan, Kenneth ; Savani, Bipin N. ; Olsson, Richard F. ; Rizzieri, David ; Steinberg, Amir ; Speckhart, Dawn ; Szwajcer, David ; Schoemans, Helene ; Seo, Sachiko ; Ustun, Celalettin ; Atsuta, Yoshiko ; Dalal, Jignesh ; Sales‐Bonfim, Carmem ; Khera, Nandita ; Hahn, Theresa ; Saber, Wael

Cancer, 2017-05, Vol.123 (10), p.1828-1838 [Periódico revisado por pares]

United States: Wiley Subscription Services, Inc

Texto completo disponível

Citações Citado por

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.